Email this article 
Hide
Show all
OPEN ACCESS | 
PEER-REVIEWED |
RESEARCH ARTICLE
|
DOWNLOAD PDF
|
VIEW FULL-TEXT PDF
| TOTAL VIEWS
Development and validation of different spectrophotometric and chromatographic methods for determination of clotrimazole and hydrocortisone in a topical cream
Michel Yousry Fares (1,*)
, Maha Mohamed Abdelrahman (2) , Hamdy Mohamed Abdel-Rahman (3) , Nada Sayed Abdelwahab (4) (1) Pharmaceutical Chemistry Department, Faculty of Pharmacy, Nahda University, Sharq El-Nile, 62511 Beni-Suef, Egypt
(2) Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, 62514 Beni-Suef, Egypt
(3) Medicinal Chemistry Department, Faculty of Pharmacy, Assiut University, 71526 Assiut, Egypt
(4) Analytical Chemistry Department, Faculty of Pharmacy, Beni-Suef University, 62514 Beni-Suef, Egypt
(*) Corresponding Author
Received: 31 Aug 2017 | Revised: 07 Oct 2017 | Accepted: 08 Oct 2017 | Published: 31 Dec 2017 | Issue Date: December 2017
Abstract
In this study, we developed and validated different spectrophotometric and chromatographic methods for determination of clotrimazole (CLO) and hydrocortisone (HDC) in their combined dosage form. The developed spectrophotometric methods were first derivative spectrophotometry (1D) by measuring the peak amplitude at 247.4 and 236.2 nm for CLO and HDC, respectively, second derivative of ratio spectra (2DD) at 225.4 nm for CLO and 269 nm for HDC, dual wavelength spectrophotometry (DW) by measuring absorbance difference between 225.4 and 264 nm for CLO and between 228 and 247 nm for HDC determination, advanced absorbance subtraction method (AAS) between 225.4 and 264 nm and mean centering of ratio spectra (MCR) spectrophotometric method in the range of 232-265 nm. On the other hand, the proposed chromatographic method was Ultra Performance Liquid Chromatography method (UPLC) using acetonitrile:water (50:50, v:v) as a mobile phase and the peaks were detected at 228 nm. All these methods were successfully applied to determine the two studied drugs in pure forms; laboratory prepared mixtures and combined dosage form. Methods validations were carried out regarding linearity, accuracy, precision and selectivity. The spectrophotometric methods exhibited a linear dynamic range over 5-40 and 5-45 µg/mL for CLO and HDC, respectively, and over 3-35 and 5-50 µg/mL for UPLC method. Sensitive and selective spectrophotometric and UPLC methods for the determination of clotrimazole and hydrocortisone in their topical formulation were successfully developed and validated. The developed methods were statistically confirmed to be accurate, precise and reproducible.
Announcements
One of our sponsors will cover the article processing fee for all submissions made between May 17, 2023 and May 31, 2023 (Voucher code: SPONSOR2023).
Editor-in-Chief
European Journal of Chemistry
Keywords
Full Text:
PDF
DOI: 10.5155/eurjchem.8.4.371-377.1646
Links for Article
| | | | | | |
| | | | | | |
| | | |
Related Articles
Article Metrics
This Abstract was viewed 1578 times |
PDF Article downloaded 528 times
Citations
[1]. Maha M. Abdelrahman, Selvia M. Adly, Nourudin W. Ali, Nada S. Abdelwahab
Development and Validation of Different Spectrophotometric and High-Performance Thin-Layer Chromatographic Methods for the Determination of Fosinopril Sodium, Hydrochlorothiazide, and Chlorothiazide as Hydrochlorothiazide Impurity
JPC - Journal of Planar Chromatography - Modern TLC 32(5), 411, 2019
DOI: 10.1556/1006.2019.32.5.9
[2]. Mahmoud Mohamed Abbas, Amira Mabrouk El-Kosasy, Lobna Abd El-Aziz Hussein, Nancy Magdy Hanna
Universal procedures for spectrophotometric determination of anticoccidial drugs; application to multi-ingredient veterinary formulation and computational investigations for multivariate analysis
European Journal of Chemistry 12(4), 368, 2021
DOI: 10.5155/eurjchem.12.4.368-376.2144
[3]. Kanaka Parvathi Kannaiah, Abimanyu Sugumaran, Hemanth Kumar Chanduluru
Simultaneous estimation of crotamiton and hydrocortisone by RP-UPLC using green analytical principles embedded analytical quality by design (AQbD) method
Microchemical Journal 184, 108166, 2023
DOI: 10.1016/j.microc.2022.108166
References
[1]. British Pharmacopoeia Stationary Office, Medicines and Healthcare Products Regulatory Agency, Vol. II, London, United Kingdom, 2010.
[2]. Sweetman, S. C., Martindale: The Complete Drug Reference, 36th Edition, Pharmaceutical Press, 2009.
[3]. Craig, R., Lippincott Modern Pharmacology with Clinical Applications, 5th Edition, Little, Brown & Company, Boston, MA, 2011.
[4]. Parker, K. Goodman and Gilman's -The Pharmacological Basis of Therapeutics, 11th Edition, The McGraw-Hill Companies, 2005.
[5]. Farhadi, K.; Maleki, R. J. Pharm. Biomed. Anal 2002, 30, 1023-1033.
https://doi.org/10.1016/S0731-7085(02)00440-5
[6]. Mahmood, S.; Ahmad, Z.; Aslam, M.; Naeem, F.; Hussain, A.; Kumar, N. Int. J. Pharm. Sci. Rev. Res. 2015, 32, 55-58.
[7]. Abdelmageed, O. H.; Khashaba, P. Y. Talanta 1993, 40(8), 1289-1294.
https://doi.org/10.1016/0039-9140(93)80200-B
[8]. Parmar, P.; Mehta, A. Indian J. Pharm. Sci 2009, 4, 451-454.
https://doi.org/10.4103/0250-474X.57299
[9]. Talaviya, S.; Majmudar, F. World J. Pharm. Pharm. Sci. 2014, 3, 397-409.
[10]. Abbas, B.; Mahmoud, N.; Ismail, R.; Gadalla, N. Chem. Pharm. Bull. J. 2008, 56, 143-149.
https://doi.org/10.1248/cpb.56.143
[11]. Abdel-Moety, E. M.; Khattab, F. I.; Kelani, K. M. AbouAl-Alamein, A. M. Il Farmaco 2002, 57, 931-938.
https://doi.org/10.1016/S0014-827X(02)01270-3
[12]. Boer, H.; Lansaat, P.; Van Oort, W. J. Anal. Chim. Acta 1980, 116, 69-76.
https://doi.org/10.1016/S0003-2670(01)84315-4
[13]. Holak, W.; Plank, W. M. J. Pharm. Sci. 1980, 69, 1436-1438.
https://doi.org/10.1002/jps.2600691223
[14]. Gallego, J.; Arroyo, J. P. Anal. Chim. Acta 2002, 460, 85-97.
https://doi.org/10.1016/S0003-2670(02)00138-1
[15]. Nightingale, C. H.; Indelicato, M. J. Pharm. Sci. 1979, 68, 1374-1376.
https://doi.org/10.1002/jps.2600681109
[16]. Pyka, A.; Babuska-Roczniak, M.; Bochenska, P. J. Liq. Chromatogr. Relat. Technol. 2011, 34(9), 753-769.
https://doi.org/10.1080/10826076.2011.563891
[17]. Grippa, E.; Santini, L.; Castellano, G.; Gatto, M. T.; Leone, M.; Saso. L. J. Chromatogr. B 2000, 738, 17-25.
https://doi.org/10.1016/S0378-4347(99)00478-8
[18]. Alvinerie, M.; Toutain, P. L. J. Pharm. Sci. 1982, 71(7), 816-818.
https://doi.org/10.1002/jps.2600710724
[19]. Derendorf, H.; Rohdewald, P.; Hochhaus, G.; Mallmann, H. J. Pharm. Biomed. Anal. 1986, 4, 197-206.
https://doi.org/10.1016/0731-7085(86)80042-5
[20]. Doppenschmitt, S. A.; Scheidel, B.; Harrison, F.; Surmann, J. J. Chromatogr. B Biomed. Sci. Appl. 1995, 674, 237-246.
https://doi.org/10.1016/0378-4347(95)00317-7
[21]. Doppenschmitt, S. A.; Scheidel, B.; Harrison, F.; Surmann, J. J. Chromatogr. B Biomed. Appl. 1996, 682, 79-88.
https://doi.org/10.1016/0378-4347(96)00060-6
[22]. Rego, A.; Nelson, B. J. Pharm. Sci. 1982, 71, 1219-1223.
https://doi.org/10.1002/jps.2600711109
[23]. Ray, J. A.; Kushnir, M. A.; Rockwood, L.; Meikle, A. W. Clin. Chim. Acta 2011, 412, 1221-1228.
https://doi.org/10.1016/j.cca.2011.03.016
[24]. Mulholland, M.; Whelan, T. J.; Rose, H.; Keegan, J. J. Chromatogr. A 2000, 870, 135-141.
https://doi.org/10.1016/S0021-9673(99)00916-4
[25]. Kushnir, M. M.; Neilson, R.; Roberts, W. L.; Rockwood, A. L. Clin. Biochem 2004, 37, 357-362.
https://doi.org/10.1016/j.clinbiochem.2004.01.005
[26]. Genete, G.; Hymete, A.; Ahmed, B. A. J. Chil. Chem. Soc. 2012, 57(3), 1199-1203.
https://doi.org/10.4067/S0717-97072012000300001
[27]. International Conference on Harmonisation (ICH). Validation of Analytical Procedures: Text and Methodology Q2(R1), ICH, 2005.
[28]. Bridge, T. P.; Fell, F.; Wardman. R. H. J. Soc. Dye. Color 1987, 103, 17-27.
https://doi.org/10.1111/j.1478-4408.1987.tb01081.x
[29]. Kus, S.; Marczenko, Z.; Obarski, N. Chem. Anal. (Warsaw) 1996, 41, 899-927.
[30]. Lotfy, H. M.; Hegazy, M.; Rezk, M. R. Omran, Y. R. Spectrochim. Acta A 2015, 148, 328-337.
https://doi.org/10.1016/j.saa.2015.04.004
[31]. Lotfy, H. M.; Saleh, S. S. Int. J. Pharm. Pharm. Sci. 2016, 8(10), 40-56.
https://doi.org/10.22159/ijpps.2016v8i10.13537
[32]. Afkhami, A.; Bahram, M. Talanta 2005, 66, 712-720.
https://doi.org/10.1016/j.talanta.2004.12.004
[33]. USP34-NF29, System suitability for chromatography, United States Pharmacopeial Convention Inc., Rockville, MD, 2011.
How to cite
The other citation formats (EndNote | Reference Manager | ProCite | BibTeX | RefWorks) for this article can be found online at: How to cite item
DOI Link: https://doi.org/10.5155/eurjchem.8.4.371-377.1646
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
| 
Save to Zotero
Save to Mendeley
European Journal of Chemistry 2017, 8(4), 371-377 | doi: https://doi.org/10.5155/eurjchem.8.4.371-377.1646 | Get rights and content
Refbacks
- There are currently no refbacks.
Copyright (c)
© Copyright 2010 - 2023 • Atlanta Publishing House LLC • All Right Reserved.
The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.
Copyright 2010-2023 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 2850 Smith Ridge Trce Peachtree Cor GA 30071-2636, USA. Registered in USA.